California's Stem Cell/Gene Therapy Agency, a Man Named Marks and the Future
His departure unsettles biomedical world and investors
Nobody knows who Peter Marks is. Or at least 99.8 percent* of Americans don’t. However, over the past several days, Marks made a few modest headlines in the mainstream media and more in the biomedical world.
Until last week, Peter Marks was the director of the Center for Biologics Evaluation and Research (CBER) at the Food and Drug…
